P
Paul Fockens
Researcher at University of Amsterdam
Publications - 667
Citations - 34870
Paul Fockens is an academic researcher from University of Amsterdam. The author has contributed to research in topics: Medicine & Colonoscopy. The author has an hindex of 90, co-authored 613 publications receiving 29905 citations. Previous affiliations of Paul Fockens include Erasmus University Rotterdam & VU University Amsterdam.
Papers
More filters
Journal ArticleDOI
Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus.
Jan B F Hulscher,Johanna W. van Sandick,Angela G. E. M. de Boer,Bas P. L. Wijnhoven,Jan G.P. Tijssen,Paul Fockens,Peep F. M. Stalmeier,Fiebo J.W. ten Kate,Herman van Dekken,Huug Obertop,Hugo W. Tilanus,J. Jan B. van Lanschot +11 more
TL;DR: Although median overall, disease-free, and quality-adjusted survival did not differ statistically between the groups, there was a trend toward improved long-term survival at five years with the extended transthoracic approach.
Journal ArticleDOI
European evidence-based guidelines on pancreatic cystic neoplasms
Marco Del Chiaro,Marc G. Besselink,Lianne Scholten,Marco J. Bruno,Djuna L. Cahen,Thomas M. Gress,Jeanin E. van Hooft,Markus M. Lerch,Julia Mayerle,Thilo Hackert,Sohei Satoi,Alessandro Zerbi,David Cunningham,Claudio De Angelis,Marc Giovanni,Enrique de-Madaria,Péter Hegyi,Jonas Rosendahl,Helmut Friess,Riccardo Manfredi,Philippe Lévy,Francisco X. Real,Alain Sauvanet,Mohammed Abu Hilal,Giovanni Marchegiani,Irene Esposito,Paula Ghaneh,Marc R. W. Engelbrecht,Paul Fockens,Nadine C.M. van Huijgevoort,Christopher L. Wolfgang,Claudio Bassi,Natalya Gubergrits,Caroline S. Verbeke,Günter Klöppel,Aldo Scarpa,Giuseppe Zamboni,Anne Marie Lennon,Malin Sund,Nikolaos Kartalis,Lars Grenacher,Massimo Falconi,Urban Arnelo,Kostantin V. Kopchak,Kofi Oppong,Colin J. McKay,Truls Hauge,Kevin C. Conlon,Mustapha Adham,Güralp O. Ceyhan,Roberto Salvia,Christos Dervenis,Peter J. Allen,François Paye,Detlef K. Bartsch,Matthias Löhr,Massimiliano Mutignani,Johanna Laukkarinen,Richard D. Schulick,Roberto Valente,Thomas Seufferlein,Gabriele Capurso,Ajith K. Siriwardena,John P. Neoptolemos,Aldis Pukitis,Ralf Segersvärd,Ali A. Aghdassi,Stefano Andrianello,Peter Bossuyt,Robin Bülow,Karina Cárdenas-Jaén,P. Cortegoso,Martina Fontana,Lena Haeberle,M. Heckler,Andrey Litvin,Kulbir Mann,Christoph W. Michalski,Patrick Michl,Gennaro Nappo,Giampaolo Perri,S. Persson,F. Scheufele,Francesco Sclafani,Manuel Schmidt,L. Venezia,F. Volker,M-P Vullierm,L. Wusten +88 more
TL;DR: A conservative approach is recommended for asymptomatic MCN and IPMN, and Lifelong follow-up of IPMN is recommended in patients who are fit for surgery.
Journal ArticleDOI
Colorectal polypectomy and endoscopic mucosal resection (EMR): European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline
Monika Ferlitsch,Alan C. Moss,Cesare Hassan,Pradeep Bhandari,Jean-Marc Dumonceau,Gregorios A. Paspatis,Rodrigo Jover,Cord Langner,Maxime E. S. Bronzwaer,Kumanan Nalankilli,Paul Fockens,Rawi Hazzan,Ian M. Gralnek,Michael Gschwantler,Elisabeth Waldmann,Philip Jeschek,D Penz,D. Heresbach,Leon M G Moons,Arnaud Lemmers,Konstantina D. Paraskeva,Juergen Pohl,Thierry Ponchon,Jaroslaw Regula,Alessandro Repici,Matthew D. Rutter,Nicholas G. Burgess,Nicholas G. Burgess,Michael J. Bourke,Michael J. Bourke +29 more
TL;DR: ESGE recommends that the goals of endoscopic mucosal resection (EMR) are to achieve a completely snare-resected lesion in the safest minimum number of pieces, with adequate margins and without need for adjunctive ablative techniques.
Journal ArticleDOI
Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
Leo G. van Rossum,Anne F. van Rijn,Robert J.F. Laheij,Martijn G.H. van Oijen,Paul Fockens,Han van Krieken,André L. M. Verbeek,Jan B.M.J. Jansen,Evelien Dekker +8 more
TL;DR: G-FOBT significantly underestimates the prevalence of advanced adenomas and cancer in the screening population compared with I-FO BT, and the number-to-scope to find 1 cancer was comparable between the tests.
Journal ArticleDOI
Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial.
Jikke M.T. Omloo,Sjoerd M. Lagarde,Jan B F Hulscher,Johannes B. Reitsma,Paul Fockens,Herman van Dekken,Fiebo J.W. ten Kate,Huug Obertop,Hugo W. Tilanus,J. Jan B. van Lanschot +9 more
TL;DR: There is no significant overall survival benefit for either approach, however, compared with limited transhiatal resection extended transthoracic esophagectomy for type I esophageal adenocarcinoma shows an ongoing trend towards better 5-year survival.